Chapter 1 - Drug Development and Ethical Considerations Flashcards
the right to self-determination
autonomy
the duty to do good and to not harm others
beneficence
principle that all people be treated fairly, including equal access to health care for all
justice
subjects in thisgroup receive the treatment or drug under the study. They are randomly assigned and not selected. They should have similar baseline characteristics to those in the control group. They do not receive a placebo
experimental group
performed in animals or other living organisms
preclinical in vivo testing
which phase of clinical experimentation do researchers test a new drug or treatment in a mall group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects
Phase 1
which phase of clinical experimentation is the drug or treatment given to al larger group of people to see if it is effective and to further evaluate its safety.
Phase 2
which phase of clinical experimentation is the drug or treatment given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the durum or treatment to be used safely
Phase 3
which phase of clinical experimentation stored are done after the drug or treatment has been marketed to gather information on the drug’s effects in various populations and to assess any side effects associated with long term use
Phase 4
which group in a study may receive not drug, a different drug, a placebo, or the same drug with a different dose, route or frequency of administration
control group
requires health care professionals to tell the truth
veracity
which act requires the drugs intended for use in children to be tested on children
US Food and Drug Administration Modernization Act of 1997
what designation is given to drugs that have met high standards for therapeutic use, patient safety, quality, purity, strength, packaging safety, and dosage form.
“United States Pharmacopeia (USP)”
who classifies controlled substance with Roman numerals from I-V
FDA
what requires drug manufacturers to test drugs in children
Pediatric Research Equity Act